Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life

Clinical and Experimental Hypertension

Volumn 31, Issue 8, 2009, Pages 680-689

  Okano, Yasuko ^a   Tamura, Kouichi ^a   Masuda, Shinitirou ^a   Ozawa, Motoko ^a   Tochikubo, Osamu ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Ambulatory blood pressure monitoring; Angiotensin || receptor blocker; Autonomic function; Health related QOL

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; LOSARTAN; OLMESARTAN; TELMISARTAN; VALSARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MALE; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; FEMALE; HEART RATE; HUMANS; HYPERTENSION; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; QUALITY OF LIFE; SYMPATHETIC NERVOUS SYSTEM; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 72749123571     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641960903407041     Document Type: Article

References (27)

1. Mancia G, Zanchetti A, Agebiti-Rosei E, Benemio G, Cesaris RD, Fogari R, Pessino A, Porcellati C, Salvetti A, Trimarco B. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997;95:1464-1470.
2. Fagard RH, Staessen JA, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens 1997;15(part 1):1493-1502
3. Palatini P, Penzo M, Racioppa A, Zugno E, Guzzardi G, Anaclerio M, Pessina AC. Clinical relevance of night-time blood pressure and of daytime blood pressure variability. Arch Intern Med 1992;152:1855-1860.
4. Fagher B, Valind S, Thulin T. End-organ damage in treated severe hypertension: Close relation to nocturnal blood pressure. J Hum Hypertens 1995;9:605-610.
5. Tochikubo O, Hishiki S, Miyajima E, Ishii M. Statistical base value of 24-h blood pressure distribution in patients with essential hypertension. Hypertension 1998;32:430-436.
6. Erickson SR, Williams BC, Gruppen LD. Perceived symptoms and health-related quality of life reported by uncomplicated hypertensive patients compared to normal controls. J Hum Hypertens 2001;15:539-548.
7. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcome study: An application of methods for monitoring the results of medical care. JAMA 1989; 262:925-930.
8. Okano Y, Tochikubo O, Umemura S. Relationship between base blood pressure during sleep and health-related quality of life in healthy adults. J Hum Hypertens 2007;21:135-140.
9. Cohn JN, Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Eng Med 2001;345:1667-1675.
10. Uchida H, Nakamura Y, Kaihara M, Sugimoto T, Norii H, Sasaki M, Sato H, Makino H. Practical efficacy of telmisartan for decreasing morning home blood pressre and pulse wave velocity in patients with mild-tomoderate hypertension. Hypertens Res 2004;27:545-550.
11. Clark S, Fowler S, Coats A, Radaelli A, van der Putt M, Bird R, Conway J. Ambulatory blood pressure monitoring: Validation of the accuracy and reliability of the TM2420 accoding to the AAMI recommendations. J Hum Hypertens 1991;5:77-82.
12. Palantini P, Penzo M, Canali C, Pessina AC. Validation of the A&D TM-2420 model 7 for ambulatory blood pressure monitoring and effect of microphone replacement on its performance. J Ambul Monit 1991;4:281-288.
13. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996;27:1318-1324.
14. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985;248:H151-H153.
15. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol 1998;11:1037-1044.
16. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol 1998;11:1045-1053.
17. Sokolow M, Werdegar D, Kain HK, Hinman AT. Relationship between level of blood pressure measured casually and by portable and severity of complications in essential hypertension. Circulation 1966;34:279-298.
18. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressure. JAMA 1983;249:2792-2798.
19. Timio M, Venanzi S, Lolli S, Lippi G, Verdura C, Monarca C, Guerrini E. Non-dipper'' hypertensive patients and progressive renal insufficiency: A 3-year longitudinal study. Clin Nephrol 1995;43:382-387.
20. Miller JA, Curtis JR, Sochett EB. Relationship between diurnal blood pressure, renal hemodynamic function, and the rennin-angiotensin system in type1 diabetes. Diabetes 2003;52:1806-1811.
21. Wolk R, Kulakowski P, Ceremuzynski L. Nifedipine and captopril exert divergent effects on heart rate variability in patients with acute episodes of hypertension. J Hum Hypertens 1996; 10:327-332.
22. Klein I, Ligtenberg G, Oey PL Koomans HA, Blankestijin PJ. Enalapril and Losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003;14:425-430.
23. Sakata K, Kumagami H, Osaka M, Onami T, Matsuura T, Imai M, Saruta T. Potentiated sympathetic nervous and renin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Circulation 2002;106:620-625. (Pubitemid 34827714)
24. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotension? receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 2006;290:H1706-1712.
25. Kum LC, Yip GW, Lee PW, Lam YY, Wu EB, Chan AK, Fung JW, Chan JY, Zhang Q, Kong SL, Yu CM. Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure. Int J Cardiol 2008;125:16-21.
26. Dahlöf B, Lindholm LH, Carney S, Pentikäinen PJ, Östergren J. Main results of the losartan versusamlodipine (LOA) study on drug tolerability and psychological general well-being. J Hypertens 1997;15:1327-1335.
27. Yamamoto S, Kawashima T, Kunitake T, Koide S, Fujimoto H. The effects of replacing dihydropyridine calcium-channel blockers with angiotensin || receptor blocker on the quality of life of hypertensive patients. Blood Press Suppl 2003;2:22-28.